the High Authority for Health justifies its negative opinion for the reimbursement of a potential treatment

the High Authority for Health justifies its negative opinion for the reimbursement of a potential treatment

At the end of October, the HAS refused “early” access to Biogen’s Qalsody, indicated in a rare genetic form of the pathology, which aroused the anger of patients. On October 25, the opinion of the High Authority for Health (HAS) had the effect of a cold shower for patients suffering from a rare form of … Read more

a more effective and less toxic treatment is proven in the United States

a more effective and less toxic treatment is proven in the United States

DECRYPTION – A clinical trial shows the benefits of combining immunotherapy and chemotherapy against this cancer which occurs half of the time before the age of 35. But the American experience will not be directly applicable to France, because the reference protocol is different. For the American doctorsit is a “practice changing” study: its results, … Read more